India, Oct. 15 -- OPKO Health, Inc. (OPK) is up 16.13 percent, gaining $0.2210 to $1.5910 on Thursday. The rally follows an agreement for Labcorp to acquire select assets of OPKO's wholly owned subsidiary BioReference Health for $722 million in cash at closing, plus upto $150 million in additional earnout payments tied to revenue from the 4Kscore Test.
OPKO Health is currently trading at $1.5910, up from the previous close of $1.3700 after opening at $1.6450 on the Nasdaq. The stock has traded between $1.5200 and $1.6500 during the session. Trading volume has surged to 30.99 million shares, compared with average volume of 3.24 million shares.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
The transac...